Anti-heparin-platelet factor 4 antibodies after cardiopulmonary bypass: role of HLA expression
Paparella, D.; Micelli, M.; Favoino, B.; D'Alò, M.; Fiore, T.; de Luca Tupputi Schinosa, L.
Haematologica 86(3): 326-327
2001
ISSN/ISBN: 0390-6078 PMID: 11255285 Document Number: 533543
Document emailed within 1 workday
Related Documents
Sakata, T. 2013: New stream for the measurement of anti-platelet factor 4/heparin antibodies Rinsho Byori. Japanese Journal of Clinical Pathology 61(2): 137-143Inui, K. 1993: Participation of platelet activating factor in the pulmonary injury during cardiopulmonary bypass Nihon Kyobu Geka Gakkai 41(2): 238-246
Párama, J.A.; Llorens, R.; Sáenz de Buruaga, J.; Rocha, E. 1994: Low-molecular-weight heparin in a patient with heparin-induced thrombocytopenia and a cardiopulmonary bypass Medicina Clinica 102(16): 637-638
Suehiro, S.; Shibata, T.; Sasaki, Y.; Hattori, K.; Kumano, H.; Hosono, M.; Kinoshita, H. 1999: Use of heparin-coated cardiopulmonary bypass circuit with low-dose heparin reduces postoperative bleeding Annals of Thoracic and Cardiovascular Surgery: Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 5(4): 225-229
Kanno, M.; Edanaga, M.; Mizukami, N.; Tokinaga, Y.; Niiyama, Y.; Yamakage, M. 2015: Successful Management of Cardiopulmonary Bypass Using Heparin in a Patient with Previous History of Heparin-induced Thrombocytopenia Masui. Japanese Journal of Anesthesiology 64(4): 449-452
Sawai, T.; Uchida, O.; Inamori, S.; Kuro, M. 2003: Successful management after cardiopulmonary bypass without administration of protamine in a patient with severe food allergy--beneficial result with the use of heparin-coated bypass circuit Masui. Japanese Journal of Anesthesiology 52(3): 280-283
Law-Koune, J.D.; Picard, P.; Van Der Linden, T.; Michault, A.; Corbin, J.C.; Duval, G. 1988: Thrombocytopenia in leptospirosis. Role of anti-platelet antibodies Presse Medicale 17(25): 1315-1316
Linden, M.D.; Erber, W.N.; Schneider, M. 2001: Heparin management during cardiopulmonary bypass Journal of Cardiovascular Surgery 42(3): 431-433
Seguchi, M.; Nakajima, S. 1995: Induction of ICAM-1 expression on the eosinophilic leukemia cell line-3 (EoL-3) by platelet-activating factor and platelet factor 4 Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 74(3): 255-257
Arén, C.; Feddersen, K.; Rådegran, K. 1987: Comparison of two protocols for heparin neutralization by protamine after cardiopulmonary bypass Journal of Thoracic and Cardiovascular Surgery 94(4): 539-541
Shikano, K.; Shinpo, H.; Nasu, M.; Morimoto, T.; Suzuki, T.; Yada, I.; Kusagawa, M. 1981: Heparin management by activated coagulation time during cardiopulmonary bypass Kyobu Geka. Japanese Journal of Thoracic Surgery 34(12): 934-937
Isomatsu, Y.; Imai, Y.; Seo, K.; Terada, M.; Aoki, M.; Shin'oka, T. 2000: Heparin monitoring during cardiopulmonary bypass in congenital heart surgery Kyobu Geka. Japanese Journal of Thoracic Surgery 53(12): 1001-1004
Petitou, M.; Lormeau, J.C.; Choay, J. 1991: A new synthetic pentasaccharide with increased anti-factor Xa activity: possible role for anionic clusters in the interaction of heparin and antithrombin IIi Seminars in Thrombosis and Hemostasis 17(Suppl 2): 143-146
La Grange, P.d.P.; Nel, J.D.; Lessing, A.J.; Schoeman, H.S.; Pretorius, P.J. 1980: The influence of cardiopulmonary bypass and autotransfusion on platelet count South African Medical Journal 58(10): 398-400
Tamim, M.; Demircin, M.; Guvener, M.; Peker, O.; Yilmaz, M. 1999: Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass Panminerva Medica 41(3): 193-198
Akl, B.F.; Vargas, G.M.; Neal, J.; Robillard, J.; Kelly, P. 1980: Clinical experience with the activated clotting time for the control of heparin and protamine therapy during cardiopulmonary bypass Journal of Thoracic and Cardiovascular Surgery 79(1): 97-102
Shah, A.C.; Genoni, M.; Niederhäuser, U.; Maloigne, M.; Turina, M. 2000: R-hirudin (lepirudin, refludan) as an alternative anticoagulant in heparin-induced thrombocytopenia during cardiopulmonary bypass connection Schweizerische Medizinische Wochenschrift 130(23): 896-899
Uthoff, K.; Zehr, K.J.; Geerling, R.; Herskowitz, A.; Cameron, D.E.; Reitz, B.A. 1994: Inhibition of platelet adhesion during cardiopulmonary bypass reduces postoperative bleeding Circulation 90(5 Part 2): Ii269-Ii274
Yuan, S-Min. 2015: Report: Heparin-induced thrombocytopenia associated with cardiopulmonary bypass: Preliminary attempt with recombinant human thrombopoietin therapy Pakistan journal of pharmaceutical sciences 28(5): 1793-1796
Candio, J.; Prager, D. 1981: Cardiopulmonary bypass and Factor XIi deficiency Pennsylvania Medicine 84(2): 40